NTLA-2001
Intellia Therapeutics
['crispr']
first in-human in vivo #crispr editing of the ttr gene in patients with #attr amyloidosis! presented by julian gillmore at #aha22! 
MD | Physician-Scientist in Cardiology | Postdoctoral Research Fellow @BrighamWomens & @harvardmed | #HeartFailure #ClinicalTrials